London HealthTech to accelerate US expansion with Silicon Valley acquisition

Sep 11, 2018 ·


HealthTech firm Medopad has made its first acquisition to accelerate expansion in the US.

The Westminster-based company snapped up Silicon Valley AI startup Sherbit, which works with the largest healthcare systems in the US to enhance chronic disease patient care.

Medopad was founded with a mission of extending the lives of one billion people globally. Its technology is used by healthcare professionals to analyse patient data and detect life-threatening medical conditions.

In the UK, the company works with hospitals and NHS trusts including Royal Free London, Guy’s and St Thomas’, Chelsea & Westminster and Bart’s. Overseas, Medopad is working on projects in Germany, China, Singapore and elsewhere.

Dan Vahdat, CEO and founder of Medopad, said: "At Medopad we want to create a world where people can live longer.

"We are working with some of the biggest companies in the world to improve the way doctors care for their patients by monitoring them at home and spotting any complications before they arise."

Read Complete Article

RT @L_Pbusiness: UK leads the way on AI ethics as @GOVUK release code of conduct for #AI technologies used in the @NHSuk ensuring only the…

Inspirational to meet these residents in their new council homes today – a fantastic example of what can be achieve…

We're pleased to welcome @UKPriyaGuha back as a #LTW Ambassador for 2019! See who else is supporting us this year →…

Dublin Airport was forced to suspend all flights due to a 'confirmed sighting of a drone' over its airfield

Four in 10 private companies are reporting wider gender pay gaps than they did last year: